better for weight loss semaglutide or tirzepatide vs Semaglutide: 2026 Clinical Comparison Semaglutide vs Tirzepatide: Is Tirzepatide

[3] Next-Generation Dual and Multi-Targeted Therapies on the Rise Amycretin: A Promising Dual GLP-1/Amylin Receptor Agonist Also making headlines at ADA 2025 was Amycretin (NNC0487-0111), a novel, unimolecular GLP-1 and amylin receptor agonist under development by Novo Nordisk

Abrupt stopping triggers a rebound effect where your body rapidly increases appetite to compensate for the sudden loss of appetite suppression

Only very briefly

The longer-term efficacy of DPP-4 inhibition was examined in a third study published later in the same year, this time undertaken in patients with T2DM on metformin monotherapy

S.VelaL

What the Research Actually Shows The same 2026 study mentioned above looked at this concern head-on, across four animal studies and an early clinical trial in people